Text Size
1 study found for:    8827967 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Targeted Laser With Lucentis 0.5mg Verses Lucentis 0.5mg Monotherapy for Ischemic Central Vein Occlusion
Condition: Ischemic Central Retinal Vein Occlusion
Interventions: Drug: 0.5mg Ranibizumab;   Procedure: Targeted Pan Retinal Photocoagulation
To Top

† Indicates status has not been verified in more than two years